Adjuvant Hormonal Therapy for Premenopausal Women With Breast Cancer

Regina J. Brown, Nancy E. Davidson

Research output: Contribution to journalArticlepeer-review

Abstract

Endocrine therapy is a required element of the management of premenopausal women with early-stage steroid hormone receptor-positive breast cancer. There is uncertainty about how best to implement that therapy using the strategies of tamoxifen and estrogen deprivation as well as how to integrate these approaches with chemotherapy. Other research focuses on identification of improved markers for endocrine response or resistance and on the special side effects of endocrine therapy in young women.

Original languageEnglish (US)
Pages (from-to)657-663
Number of pages7
JournalSeminars in oncology
Volume33
Issue number6
DOIs
StatePublished - Dec 2006

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Adjuvant Hormonal Therapy for Premenopausal Women With Breast Cancer'. Together they form a unique fingerprint.

Cite this